https://business24.ch/2020/11/02/corlieve-therapeutics-sas-schliesst-die-seed-finanzierung-zur-entwicklung-von-therapien-fuer-schwere-neurologische-erkrankungen/Mon, 02 Nov 2020 19:00:04 +0000 https://business24.ch/?p=4823348233